48) This discrepancy between the outcomes of rapid depletion versus bromodomain inhibition is highly significant for therapeutic development.
← all excerpts
BRD9 at the crossroads of splicing, chromatin remodeling, and hematopoiesis.
1
—
—
48) This discrepancy between the outcomes of rapid depletion versus bromodomain inhibition is highly significant for therapeutic development.